SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-060495
Filing Date
2021-05-04
Accepted
2021-05-04 07:28:37
Documents
13
Period of Report
2021-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2115010d1_6k.htm 6-K 45048
2 GRAPHIC tm2115010d1_6kimg01.jpg GRAPHIC 368971
3 GRAPHIC tm2115010d1_6kimg02.jpg GRAPHIC 470441
4 GRAPHIC tm2115010d1_6kimg03.jpg GRAPHIC 351008
5 GRAPHIC tm2115010d1_6kimg04.jpg GRAPHIC 447515
6 GRAPHIC tm2115010d1_6kimg05.jpg GRAPHIC 289039
7 GRAPHIC tm2115010d1_6kimg06.jpg GRAPHIC 381971
8 GRAPHIC tm2115010d1_6kimg07.jpg GRAPHIC 311267
9 GRAPHIC tm2115010d1_6kimg08.jpg GRAPHIC 334731
10 GRAPHIC tm2115010d1_6kimg09.jpg GRAPHIC 204910
11 GRAPHIC tm2115010d1_6kimg010.jpg GRAPHIC 257159
12 GRAPHIC tm2115010d1_6kimg011.jpg GRAPHIC 292488
13 GRAPHIC tm2115010d1_6kimg012.jpg GRAPHIC 412865
  Complete submission text file 0001104659-21-060495.txt   5721030
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 21885992
SIC: 2834 Pharmaceutical Preparations